SPPAM
ALXN

Summit Partners Public Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Summit Partners Public Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-85,000
Closed -$11.1M – 114
2019
Q2 		$11.1M Buy
85,000
+35,270
+71% +$4.62M 1.11% 28
2019
Q1 		$6.72M Buy
+49,730
New +$6.72M 0.82% 35
2018
Q4 		– Hold
0
– – – 85
2018
Q3 		– Hold
0
– – – 89
2018
Q2 		– Hold
0
– – – 89